Bio-Optronics

Bio-Optronics

United States; New York New York United States; New York United States; North America
Is it you?
Investor info
Stage focus
  • Seed Round
Industry focus
Description
Bio-Optronics is a leading healthcare information technology company, focusing specifically on workflow optimization. Their mission is to develop and deploy software products and services to help healthcare professionals enhance quality, productivity, patient and staff satisfaction. Since 1985, Bio-Optronics has created unique and innovative software solutions for hospitals and hospital networks, medical practices, imaging centers, and all participants in the clinical trial enterprise. Their dedicated software development and customer service teams have developed and deployed software solutions that not only meet industry needs, but also set the standard for innovative healthcare solutions. Collectively the Bio-Optronics team has over a century of experience working in healthcare devices, services, clinical trials and information technology. Their deep workflow knowledge comes from their experience in manufacturing, Six Sigma, and extensive interaction with healthcare professionals.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Healthcare
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.